Inverness Counsel’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$695K Buy
9,892
+707
+8% +$55.4K 0.04% 105
2022
Q2
$736K Sell
9,185
-2,138
-19% -$167K 0.04% 93
2022
Q1
$859K Sell
11,323
-168,363
-94% -$13.3M 0.04% 97
2021
Q4
$15.3M Sell
179,686
-174,966
-49% -$13.7M 0.57% 42
2021
Q3
$26.8M Sell
354,652
-25,583
-7% -$2.03M 0.98% 34
2021
Q2
$30.9M Sell
380,235
-33,858
-8% -$2.77M 1.13% 30
2021
Q1
$32.6M Sell
414,093
-23,453
-5% -$1.84M 1.35% 26
2020
Q4
$37.4M Sell
437,546
-28,949
-6% -$2.39M 1.53% 26
2020
Q3
$36M Buy
466,495
+50,523
+12% +$3.85M 1.61% 26
2020
Q2
$30.5M Buy
415,972
+38,773
+10% +$2.75M 1.52% 21
2020
Q1
$25M Buy
+377,199
New +$26.6M 1.57% 21

Other funds holding CL

Inverness Counsel's CL Position: Q3 2022 in Review

Inverness Counsel increased its Colgate-Palmolive (CL) stake by 7.7% in Q3 2022, buying an estimated $55.4K and bringing the position to 9,892 shares worth $695K. The position accounts for 0.04% of the portfolio, ranked #105.

Inverness Counsel first reported a position in CL in Q1 2020 and has held it in 11 quarters since. The position peaked at $37.4M in Q4 2020. 1,615 funds tracked by Wall St. Rank hold CL as of Q3 2022.

  • Inverness Counsel held 9,892 shares of Colgate-Palmolive worth $695K as of Q3 2022.
  • Inverness Counsel bought 707 Colgate-Palmolive shares in Q3 2022, an estimated $55.4K.
  • Colgate-Palmolive made up 0.04% of Inverness Counsel's portfolio in Q3 2022, its #105 holding.
  • Inverness Counsel first reported a position in Colgate-Palmolive in Q1 2020 and has held it in 11 quarters since.
  • Inverness Counsel's Colgate-Palmolive position peaked at $37.4M in Q4 2020.
  • 1,615 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2022.

Based on Inverness Counsel's 13F filing for Q3 2022, filed 26 Oct 2022.